SLC5A2 and non-small cell lung carcinoma: To determine if GlucoGlo could label NSCLC in in vivo mouse models, female nude athymic mice bearing SGLT2-expressing H1299 flank xenografts were administered GlucoGlo at 0.05 mg/kg via tail vein injection.